TY - JOUR
T1 - Triangular titanium implants for minimally invasive sacroiliac joint fusion
T2 - 2-year follow-up from a prospective multicenter trial
AU - SIFI Study Group
AU - Duhon, Bradley S.
AU - Bitan, Fabien
AU - Lockstadt, Harry
AU - Kovalsky, Don
AU - Cher, Daniel
AU - Hillen, Travis
AU - Wilhite, Elaine
AU - Farris, James
AU - Newman, Cristy
AU - Pestka, Laura
AU - Tao, Cheng
AU - Makowski, Jackie
AU - Kelly, Toni
AU - Meyer, S. Craig
AU - Jones, Vicki
AU - Vogt, Michelle
AU - Kutz, Scott
AU - Thompson, Linda
AU - Kondrashov, Dimitriy
AU - Kondrashov, Irina
AU - Redmond, Andy J.
AU - Piazza, Jennifer
AU - Doredant, Laurie
AU - Short, Beth
AU - Mayfield, Jessica
AU - Soo, C. L.
AU - White, Julie
AU - Haynes, Kallena
AU - Pfister, Amber
AU - Mesiwala, Ali
AU - Bose, Stephanie
AU - Rudolf, Leonard
AU - Thibodeau, John
AU - Stevenson, Kevin
AU - Mahoney, Logan
AU - Gomez, Stephanie
AU - Stevenson, John
AU - Marichal, Ana
AU - Sachs, Donald
AU - Cambron, Robin
AU - White, Missy
AU - Colburn, Ana
AU - Raiden, Sally
AU - Chowdhary, Abhineet
AU - Fortney, Tina
AU - Thaiyananthan, Gowriharan
AU - Williams, Tungie
AU - Oh, Michael
AU - Schmidt, Gary
AU - Yeager, Matthew
N1 - Publisher Copyright:
© 2016 ISASS.
PY - 2015
Y1 - 2015
N2 - Background Sacroiliac joint (SIJ) dysfunction is an underdiagnosed condition. Several published cohorts have reported favorable mid-term outcomes after SIJ fusion using titanium implants placed across the SIJ. Herein we report long-term (24-month) results from a prospective multicenter clinical trial. Methods One hundred and seventy-two subjects at 26 US sites with SI joint dysfunction were enrolled and underwent minimally invasive SI joint fusion with triangular titanium implants. Subjects underwent structured assessments preoperatively and at 1, 3, 6, 12, 18 and 24 months postoperatively, including SIJ pain ratings (0-100 visual analog scale), Oswestry Disability Index (ODI), Short Form-36 (SF-36), EuroQOL-5D (EQ-5D), and patient satisfaction. Adverse events were collected throughout follow-up. All participating patients underwent a high-resolution pelvic CT scan at 1 year. Results Mean subject age was 50.9 years and 69.8% were women. SIJ pain was present for an average of 5.1 years prior to surgical treatment. SIJ pain decreased from 79.8 at baseline to 30.4 at 12 months and remained low at 26.0 at 24 months (p<.0001 for change from baseline). ODI decreased from 55.2 at baseline to 31.5 at 12 months and remained low at 30.9 at 24 months (p<.0001 for change from baseline). Quality of life (SF-36 and EQ-5D) improvements seen at 12 months were sustained at 24 months. The proportion of subjects taking opioids for SIJ or low back pain decreased from 76.2% at baseline to 55.0% at 24 months (p <.0001). To date, 8 subjects (4.7%) have undergone one or more revision SIJ surgeries. 7 device-related adverse events occurred. CT scan at one year showed a high rate (97%) of bone adherence to at least 2 implants on both the iliac and sacral sides with modest rates of bone growth across the SIJ. Conclusions In this study of patients with SIJ dysfunction, minimally invasive SI joint fusion using triangular titanium implants showed marked improvements in pain, disability and quality of life at 2 years. Imaging showed that bone apposition to implants was common but radiographic evidence of intraarticular fusion within the joint may take more than 1 year in many patients.
AB - Background Sacroiliac joint (SIJ) dysfunction is an underdiagnosed condition. Several published cohorts have reported favorable mid-term outcomes after SIJ fusion using titanium implants placed across the SIJ. Herein we report long-term (24-month) results from a prospective multicenter clinical trial. Methods One hundred and seventy-two subjects at 26 US sites with SI joint dysfunction were enrolled and underwent minimally invasive SI joint fusion with triangular titanium implants. Subjects underwent structured assessments preoperatively and at 1, 3, 6, 12, 18 and 24 months postoperatively, including SIJ pain ratings (0-100 visual analog scale), Oswestry Disability Index (ODI), Short Form-36 (SF-36), EuroQOL-5D (EQ-5D), and patient satisfaction. Adverse events were collected throughout follow-up. All participating patients underwent a high-resolution pelvic CT scan at 1 year. Results Mean subject age was 50.9 years and 69.8% were women. SIJ pain was present for an average of 5.1 years prior to surgical treatment. SIJ pain decreased from 79.8 at baseline to 30.4 at 12 months and remained low at 26.0 at 24 months (p<.0001 for change from baseline). ODI decreased from 55.2 at baseline to 31.5 at 12 months and remained low at 30.9 at 24 months (p<.0001 for change from baseline). Quality of life (SF-36 and EQ-5D) improvements seen at 12 months were sustained at 24 months. The proportion of subjects taking opioids for SIJ or low back pain decreased from 76.2% at baseline to 55.0% at 24 months (p <.0001). To date, 8 subjects (4.7%) have undergone one or more revision SIJ surgeries. 7 device-related adverse events occurred. CT scan at one year showed a high rate (97%) of bone adherence to at least 2 implants on both the iliac and sacral sides with modest rates of bone growth across the SIJ. Conclusions In this study of patients with SIJ dysfunction, minimally invasive SI joint fusion using triangular titanium implants showed marked improvements in pain, disability and quality of life at 2 years. Imaging showed that bone apposition to implants was common but radiographic evidence of intraarticular fusion within the joint may take more than 1 year in many patients.
KW - Degenerative sacroiliitis
KW - Multicenter clinical trial
KW - Sacroiliac joint disruptions
KW - Sacroiliac joint dysfunction
KW - Sacroiliac joint fusion
UR - https://www.scopus.com/pages/publications/84975742295
U2 - 10.14444/3013
DO - 10.14444/3013
M3 - Article
C2 - 27162715
AN - SCOPUS:84975742295
SN - 2211-4599
VL - 10
JO - International Journal of Spine Surgery
JF - International Journal of Spine Surgery
M1 - 13
ER -